CLINICAL_TRIALS
trial_result
· 2022-12-07
Clinical Trial Update: Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders [Phase 3]
Summary
Phase 3 trial update on Dual Ovarian Stimulation (DUOSTIM) for poor ovarian responders has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Centre Hospitalier Intercommunal Creteil | Conditions: Fertility Disorders | Phase 3 | Status: COMPLETED